UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Drugs (New York, N.Y.), ISSN 0012-6667, 2007, Volume 67, Issue 13, pp. 1944 - 1945
Tacrolimus - therapeutic use | Liver Transplantation | Graft Rejection - prevention & control | Humans | Immunosuppressive Agents - therapeutic use | Immunosuppressive Agents - adverse effects | Kidney Transplantation | Patient Compliance | Tacrolimus - adverse effects | Delayed-Action Preparations | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 02/2018, Volume 102, Issue 2S Suppl 1, pp. S1 - S2
Journal Article
Transplantation, ISSN 0041-1337, 08/2020, Volume 104, Issue 8, pp. 1535 - 1536
Journal Article
American journal of transplantation, ISSN 1600-6135, 03/2019, Volume 19, Issue 3, pp. 811 - 822
immunosuppressant—mechanistic target of rapamycin: everolimus | immunosuppressant—calcineurin inhibitor: tacrolimus | clinical research/practice | immunosuppressive regimens—minimization/withdrawal | kidney transplantation/nephrology | pediatrics | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Pediatrics | Kidneys | Tacrolimus | Mycophenolic acid | Renal function | Transplants & implants | Immunoproliferative diseases | Patients | Evidence-based medicine | Glomerular filtration rate | Graft rejection | Biopsy | Lymphocytes | Mycophenolate mofetil | Steroid hormones | Kidney transplantation | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 04/2017, Volume 101, Issue 4, pp. 844 - 850
Transplantation | Immunology | Life Sciences & Biomedicine | Surgery | Science & Technology | Prednisone - adverse effects | Prospective Studies | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Risk Factors | Antibodies, Monoclonal - adverse effects | Male | Treatment Outcome | Tacrolimus - adverse effects | Mycophenolic Acid - adverse effects | Time Factors | Everolimus - adverse effects | Ultrasonography | Brazil | Adult | Female | Immunosuppressive Agents - adverse effects | Drug Therapy, Combination | Wound Healing - drug effects | Antilymphocyte Serum - adverse effects | Kidney Transplantation - adverse effects | Index Medicus | Original Clinical Science—General
Journal Article
American journal of kidney diseases, ISSN 0272-6386, 2015, Volume 67, Issue 4, pp. 648 - 659
Nephrology | tacrolimus | pill burden | transplant recipient | randomized controlled trial (RCT) | kidney transplantation | efficacy | Immunosuppression | bioavailability | treatment failure | Envarsus | safety | end-stage renal disease (ESRD) | formulation | biopsy-proven acute rejection | extended-release | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prospective Studies | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Male | Kidney Transplantation | Time Factors | Adult | Female | Aged | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 04/2019, Volume 103, Issue 4, pp. 664 - 665
Journal Article
Transplantation, ISSN 0041-1337, 09/2016, Volume 100, Issue 9, pp. 1833 - 1839
Phosphorylation | Humans | Immunosuppressive Agents - pharmacokinetics | Kidney - enzymology | Kidney - immunology | STAT Transcription Factors - metabolism | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Janus Kinase 3 - antagonists & inhibitors | Drug Dosage Calculations | Janus Kinase 3 - metabolism | Immunosuppressive Agents - administration & dosage | Graft Rejection - enzymology | Kidney - surgery | Protein Kinase Inhibitors - pharmacokinetics | Kidney - drug effects | Graft Rejection - prevention & control | Risk Factors | Treatment Outcome | Protein Kinase Inhibitors - administration & dosage | Animals | Signal Transduction - drug effects | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Drug Monitoring | Graft Survival - drug effects | Kidney Transplantation - adverse effects | Index Medicus
Journal Article
Transplant international, ISSN 0934-0874, 05/2012, Volume 25, Issue 5, pp. 592 - 602
everolimus | calcineurin inhibitor minimization | tacrolimus | mammalian target of rapamycin inhibitor | proliferation signal inhibitors | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Sirolimus - analogs & derivatives | Glomerular Filtration Rate | Graft Rejection - prevention & control | Humans | Middle Aged | Graft Rejection - etiology | Male | Treatment Outcome | Tacrolimus - adverse effects | Kidney Transplantation - methods | Calcineurin Inhibitors | Sirolimus - administration & dosage | Kidney Transplantation - physiology | Time Factors | Adult | Female | Immunosuppressive Agents - adverse effects | Kidney Transplantation - immunology | Everolimus | Immunosuppressive Agents - administration & dosage | Kidney Transplantation - adverse effects | Tacrolimus - administration & dosage | Clinical trials | Kidneys | Angiogenesis inhibitors | Tacrolimus | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 10/2014, Volume 98, Issue 8, pp. 885 - 892
Chronic rejection | Acute rejection | Graft loss | Late rejection | Kidney transplant | Transplantation | Immunology | Life Sciences & Biomedicine | Surgery | Science & Technology | Acute Disease | Glomerular Filtration Rate | Kidney - pathology | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Adult | Female | Retrospective Studies | Graft Rejection - pathology | Kidney Transplantation - adverse effects | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 04/2013, Volume 95, Issue 7, pp. 933 - 942
Renal transplantation | Renal function | Cyclosporine | Everolimus | Calcineurin inhibitor toxicity | Transplantation | Immunology | Life Sciences & Biomedicine | Surgery | Science & Technology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Cyclosporine - blood | Calcineurin Inhibitors | Glomerular Filtration Rate - drug effects | Immunosuppressive Agents - blood | Time Factors | Graft Rejection - mortality | Adult | Female | Drug Therapy, Combination | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Graft Rejection - physiopathology | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Treatment Outcome | Sirolimus - blood | Cyclosporine - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Kidney Transplantation - mortality | Graft Rejection - immunology | Drug Monitoring | Graft Survival - drug effects | Kidney Transplantation - immunology | Kidney Transplantation - adverse effects | Index Medicus
Journal Article
American journal of transplantation, ISSN 1600-6135, 01/2021, Volume 21, Issue 1, pp. 123 - 137
immunosuppressant—mechanistic target of rapamycin: everolimus | patient safety | clinical research/practice | immunosuppressive regimens—minimization/withdrawal | kidney transplantation/nephrology | graft survival | glomerular filtration rate (GFR) | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Medical research | Pediatrics | Kidneys | Corticosteroids | Tacrolimus | Medicine, Experimental | Organ transplant recipients | Mycophenolate mofetil | Corticoids | Mycophenolic acid | Drug withdrawal | Glomerular filtration rate | Graft rejection | Kidney transplants | Biopsy | Steroid hormones | Kidney transplantation | Index Medicus
Journal Article
13.
CYP3A53 and CYP2C83 variants influence exposure and clinical outcomes of tacrolimus-based therapy
Pharmacogenomics, ISSN 1462-2416, 01/2020, Volume 21, Issue 1, pp. 7 - 21
Journal Article
Transplantation, ISSN 0041-1337, 09/2018, p. 1
Journal Article
Kidney international, ISSN 0085-2538, 07/2019, Volume 96, Issue 1, pp. 27 - 30
Journal Article